Inequalities in cancer outcomes
This Cancer Research UK funded Programme has as its main ambition to reduce inequalities in cancer survival, ensuring that everyone, regardless of sociodemographic background, benefits from improvements in cancer care.
QUALITOP
This four-year ERC Horizon 2020 funded project (2020-2023), involves 13 institutions from 9 different countries and is led by the Hospices Civils de Lyon, France. It aims to develop a platform to collect, manage and analyse large datasets…
Developing a risk score for pancreatic cancer
This project on pancreatic cancer initiated in 2019, with an award from the Pancreatic Cancer Research Fund. The aim is to use historic GP and hospital data to identify patients who …
Individual and contextual deprivation
The aim of this ESRC funded project is to quantify simultaneously the impact of individual and contextual levels of deprivation on the excess mortality hazard, and to describe how the …
Policy Research Unit in Cancer Awareness
Since 2011, we have been part of the twice awarded Policy Research Unit in Cancer Awareness, Screening and Early Diagnosis funded by the NIHR Policy Research Programme.
ROBEST
This three-year (2022-2025) Medical Research Council project [grant number MR/W021021/1] will improve the robustness of the outputs in public health research.
Recent publications
- BACKGROUND: We modeled the clinical course of a cohort of diffuse large B-cell lymphoma (DLBCL) patients with no prior cardiovascular diseases (CVDs) using a multistate modeling framework. PATIENTS AND METHODS: […]
- OBJECTIVES: We aimed to assess the association between multimorbidity and deprivation on short-term mortality among patients with diffuse large B-cell (DLBCL) and follicular lymphoma (FL) in England. SETTING: The association […]
- Non-Hodgkin lymphoma is a heterogeneous group of malignancies characterised by various behaviours and prognoses. Two of the most common subtypes are diffuse large B-cell lymphoma and follicular lymphoma, where patients […]
- BACKGROUND: Cancer patients often have pre-existing comorbidities, which can influence timeliness of cancer diagnosis. We examined symptoms, investigations and emergency presentation (EP) risk among colorectal cancer (CRC) patients by comorbidity […]
- The main purpose of many medical studies is to estimate the effects of a treatment or exposure on an outcome. However, it is not always possible to randomize the study […]